JPS6447398A - Selection of blood of blood preparation contaminated with human lymphocytophilic virus - Google Patents

Selection of blood of blood preparation contaminated with human lymphocytophilic virus

Info

Publication number
JPS6447398A
JPS6447398A JP20478787A JP20478787A JPS6447398A JP S6447398 A JPS6447398 A JP S6447398A JP 20478787 A JP20478787 A JP 20478787A JP 20478787 A JP20478787 A JP 20478787A JP S6447398 A JPS6447398 A JP S6447398A
Authority
JP
Japan
Prior art keywords
blood
human
virus
lymphocytophilic
selection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP20478787A
Other languages
Japanese (ja)
Inventor
Mitsuo Yokoyama
Izumi Tsuboi
Takatsugu Imura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Maruho Co Ltd
Original Assignee
Maruho Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maruho Co Ltd filed Critical Maruho Co Ltd
Priority to JP20478787A priority Critical patent/JPS6447398A/en
Publication of JPS6447398A publication Critical patent/JPS6447398A/en
Pending legal-status Critical Current

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

PURPOSE:To enable the selection and rejection of blood or blood preparation contaminated with human lymphocytophilic virus, by determining enzymatic activity of guanase and adenosine deaminase in the human blood or blood preparation. CONSTITUTION:Blood or blood preparation contaminated with human lymphocytophilic virus is selected by determining the enzymatic activity of guanase and adenosine deaminase in the human blood or blood preparation and rejecting the blood having remarkably low guanase activity and having an adenosine deaminase activity significantly higher than normal value. The process enables the indirect and accurate selection of blood or blood preparation contaminated with human lymphocytophilic virus such as AIDS virus without using antigen antibody reaction.
JP20478787A 1987-08-17 1987-08-17 Selection of blood of blood preparation contaminated with human lymphocytophilic virus Pending JPS6447398A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP20478787A JPS6447398A (en) 1987-08-17 1987-08-17 Selection of blood of blood preparation contaminated with human lymphocytophilic virus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20478787A JPS6447398A (en) 1987-08-17 1987-08-17 Selection of blood of blood preparation contaminated with human lymphocytophilic virus

Publications (1)

Publication Number Publication Date
JPS6447398A true JPS6447398A (en) 1989-02-21

Family

ID=16496342

Family Applications (1)

Application Number Title Priority Date Filing Date
JP20478787A Pending JPS6447398A (en) 1987-08-17 1987-08-17 Selection of blood of blood preparation contaminated with human lymphocytophilic virus

Country Status (1)

Country Link
JP (1) JPS6447398A (en)

Similar Documents

Publication Publication Date Title
AU9058091A (en) Preparation of nucleic acid samples
ES8801319A1 (en) Gag antigen and its use for the detection of lav infection and in immunogenic compositions
EP0314402A3 (en) Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
DE3269343D1 (en) Inactivated target cells, methods of using same and vaccines and diagnostic kits containing same
EP0247730A3 (en) Antibodies, their preparation and use and products containing them
EP0057360A3 (en) Cyclic carbonic acid derivatives, process for their preparation and their use as copolymerisation constituents for the preparation of polycarbonates
EP0306219A3 (en) Novel hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
SE7903821L (en) KINETICAL SATURATION OF THE GLYCOSE CONCENTRATION IN BODY WELDING AND PREPARATION
ES468363A1 (en) Preparation for the treatment of Herpes zoster and other Herpes infections, as well as method for manufacture thereof
BG49719A3 (en) Method for preparing of variants chirudine and their use
AU8217387A (en) Process and device for the cultivation of immobilized or adherent mammalian cells, and the use thereof in the preparation of proteins
EP0160486A3 (en) Monoclonal antibodies
EP0300381A3 (en) Immunological detection of herbicides
JPS6447398A (en) Selection of blood of blood preparation contaminated with human lymphocytophilic virus
IE880729L (en) A process for the isolation of basement membrane proteins¹from human and animal tissues
AU2190288A (en) Vector for the expression of proteins of the HIV-2 virus, one of the casual agents of AIDS, cell culture infected or transformed by this vector, proteins obtained, vaccine and antibodies obtained
WO1988000836A3 (en) Immuno-suppressor and process for its manufacture
FI883255A (en) MAENNISKANS PAPILLOMAVIRUS, TYPE 41 DESS DNA OCH AV DNA: ET CHAMBER PROTEIN.
EP0248147A3 (en) Method of determining the presence of cancer cells
AU591290B2 (en) Rapid detection of n. gonorrhoeae without culture
Ito et al. Inactivation of human cytomegalovirus by phytohemagglutinin
ES8704268A1 (en) Method for determining the activity of the complement-system of blood.
SU1082422A1 (en) Method of determining the activity of interferon in blood serum and plasma
AU7692987A (en) Reagent kit, its use and diagnostic process for the detection of hpasp(human pancreatic specific protein)
EP0250216A3 (en) Method for determination of a " mucoprotein vector " from blood serum